Contents
Contents
DME accreditation fraud uses false records, concealed ownership or a compromised inspection to obtain the approval a supplier needs to bill Medicare. A false approval puts taxpayers behind bills for equipment patients may never have needed. The certificate says the durable medical equipment supplier meets quality standards. Someone inside the office may know who prepared the records, who really controls the business and whether the inspection tested its operations at all. Those details connect the approval on the wall to the claims sent to Medicare.
Accreditation checks a supplier against Medicare’s quality standards. Enrollment establishes its Medicare billing privileges and checks the separate supplier standards. The accrediting organization and the enrollment contractor have different jobs.
The Centers for Medicare & Medicaid Services’ accreditation guidance says the enrollment contractor verifies that the supplier has accreditation for the products and services on its application. Accreditation comes before the enrollment application unless the supplier is exempt. The accreditor reviews supporting documents and conducts an unannounced on-site survey, then reports the accreditation information to the enrollment contractor.
Approval covers specific products and locations, including subcontracted locations. Each location needs its own accreditation.
That division matters when a healthcare business presents its certificate as the answer to every question. The patient order, the way the patient was recruited, the delivery and the claim still have their own requirements. The enrollment file and the survey file describe different parts of the same business.
A site visit should test the supplier’s actual operations against the documents it submitted. The Centers for Medicare & Medicaid Services bases accreditation on both the submitted information and the on-site survey results. The paperwork should describe the business the surveyor finds on arrival.
The separate supplier standards make the business concrete: a physical facility, staff during posted hours, a permanent visible sign, a primary business telephone, insurance, a way to fill orders and proof of delivery. Suppliers also have to maintain complaint records showing what happened and how they responded.
For an office employee or surveyor, the comparison runs across those records. We look at the location identified in the application, the products covered by its accreditation, the fulfillment arrangement and the records of what reached the patient. A complaint about an undelivered item belongs beside the delivery record for that item. The question is what the paperwork represented and who knew the actual circumstances.
A durable medical equipment supplier can fill orders from its own inventory or through a contract. That makes the fulfillment contract part of the operational story: who had the equipment, who supplied it and how the supplier documented delivery.
We compare the contract shown during accreditation with the supplier’s purchasing, fulfillment and payment records. The contract describes an arrangement. The transactions show how the arrangement worked. Where an insider says the document concealed the actual supplier, that connection deserves a close look.
The Department of Health and Human Services’ Office of Inspector General gives a false-invoice example in its Medicaid Fraud Control Units Fiscal Year 2014 Annual Report, published in 2015. It describes a West Virginia civil settlement over allegations that a durable medical equipment company billed Medicare and Medicaid for back braces supplied by an excluded company. The billing company allegedly kept part of the reimbursement, passed the rest to the excluded company and used false invoices to support the billing.
Regency and its owner agreed in February 2021 to a civil settlement of up to $20,332,516 over allegations that included falsifying documents to establish durable medical equipment corporations that billed for medically unnecessary equipment. The Justice Department’s announcement also described alleged improper marketing practices involving kickbacks. A former Regency employee brought the whistleblower case included in the settlement.
The civil allegations put false business documentation at the beginning of the payment chain. The paperwork allegedly helped establish companies that could bill for equipment patients did not need.
Separately, the Justice Department’s account of the owner’s criminal guilty plea described conspirators using Regency to establish dozens of supplier fronts in straw owners’ names, concealing who controlled the companies. They claimed their unusually high billing reflected telemedicine, while doctors were bribed to approve orders and almost always had no telehealth interaction with the beneficiaries.
For an insider, the ownership papers and the patient orders are connected. One identifies the company allowed to bill. The other supplies the claimed medical reason for the bill. Knowing how either was created can expose how the business obtained government payment.
Planted patient files can make a durable medical equipment supplier appear to serve patients it never supplied. The Centers for Medicare & Medicaid Services explains in its final rule that surveyors review patient records to confirm the supplier actually serves patients and provides legitimate items and services. The rule bars mock files, fictional records, simulated documents, templates and duplicates. The records must belong to that supplier’s own patients.
The origin of a patient file matters beyond the survey, too. In its complaint against AZ Diabetic Supply, the government alleged that LPI acted as a lead-and-prescription middleman:
LPI paid telemedicine doctors to use the leads to write DME prescriptions. LPI then sold the complete prescriptions, along with each beneficiary’s personal and medical data, to DME suppliers.
United States v. AZ Diabetic Supply, Inc., government complaint, paragraph 36
The government also alleged that prescriptions reached the supplier through Dropbox or other cloud services from the middlemen, rather than directly from the patients’ providers. The files had a commercial origin that mattered to the alleged scheme.
A complete-looking file can still leave the central question unanswered: how did this patient become this supplier’s customer? We connect the file with the order, its sender, payments to that sender and the resulting claim. A person responsible for receiving or maintaining those records may know how a seemingly complete file came together.
The inspector can be part of the scheme. The Justice Department’s account of a Miami inspector’s criminal guilty plea described a contractor who accepted bribes to speed accreditation. The inspector formed durable medical equipment companies in family members’ names to conceal his interest, inspected those companies himself and obtained accreditation and Medicare approval for them. He then sold companies whose value had increased because they could bill Medicare.
The inspector was inspecting his own companies. Ownership records, family business relationships and the identity of the surveyor belonged to the same inquiry.
The Centers for Medicare & Medicaid Services’ accreditor oversight rule addresses independence as well as inspections. It requires separate staff for an accreditor’s consulting and accreditation functions, and bars accreditation staff and surveyors from marketing the organization’s consulting services to accreditation clients. The supplier pays for a review whose value depends on the reviewer’s independence.
Starting January 1, 2026, the Centers for Medicare & Medicaid Services moved accredited suppliers to resurvey and reaccreditation at least every twelve months. Suppliers with an existing three-year cycle issued before that date enter the annual cycle when their current cycle expires.
The transition matters when comparing a survey date with the period an insider describes. The agency explained that a longer interval gives a supplier more opportunity to fall out of compliance.
CMS also ended the allowance for an existing supplier’s new location to operate for three months before a site visit. Under the new requirement, that location must be surveyed before accreditation. The address in the enrollment file, the location inspected and the period of operation are facts to connect.
For supplier ownership, the DME 36-month rule generally requires a new owner to obtain new enrollment, a survey and accreditation after a majority-ownership sale within 36 months of initial enrollment or the most recent majority-ownership change.
The rule makes the ownership history relevant to the approval. We examine the business identified on the enrollment papers, the transaction and who actually controlled it. In the inspector’s case, Medicare enrollment was what made the companies more valuable to buyers.
Medicare Advantage supplier screening also depends on the plan and the supplier’s network status. HHS OIG’s September 2026 issue brief found that plans conducted fewer screening checks on out-of-network suppliers. The Centers for Medicare & Medicaid Services did not screen every durable medical equipment supplier billing Medicare Advantage because some were not enrolled in Medicare. The report identified out-of-network suppliers without Medicare enrollment as the group with the least screening and an increased fraud risk.
For that reason, we identify the payer alongside the supplier’s accreditation and enrollment records. The plan’s screening and the supplier’s approval history answer different questions about how the claims reached payment.
The useful evidence connects what the supplier represented to how it operated and what it billed. Survey submissions show the representation. Ownership and fulfillment records show who controlled the business and supplied the equipment. Patient orders, delivery records and claims connect the operation to government money.
An office employee may know who supplied a document. A surveyor may know what was presented at the location. A billing employee may know which company submitted the resulting claims. We work with that firsthand knowledge to identify the decisions behind the false paperwork.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know the survey paperwork concealed how a supplier actually operated, speak with our whistleblower experts about the approval and the claims behind it. We work beside you through the case and bring in health care fraud whistleblower lawyers who understand Medicare supplier enrollment, accreditation and billing. Put that firsthand knowledge to work with us to build your strongest Medicare supplier whistleblower case.